RedHill Biopharma (RDHL) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for RedHill Biopharma (RDHL) over the last 7 years, with Q2 2025 value amounting to -$163000.0.
- RedHill Biopharma's Other Gross PP&E Adjustments rose 6524.52% to -$163000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$163000.0, marking a year-over-year increase of 6524.52%. This contributed to the annual value of -$302000.0 for FY2024, which is 6946.41% up from last year.
- According to the latest figures from Q2 2025, RedHill Biopharma's Other Gross PP&E Adjustments is -$163000.0, which was up 6524.52% from -$302000.0 recorded in Q4 2024.
- Over the past 5 years, RedHill Biopharma's Other Gross PP&E Adjustments peaked at -$163000.0 during Q2 2025, and registered a low of -$7.7 million during Q1 2022.
- In the last 5 years, RedHill Biopharma's Other Gross PP&E Adjustments had a median value of -$4.2 million in 2021 and averaged -$3.9 million.
- In the last 5 years, RedHill Biopharma's Other Gross PP&E Adjustments plummeted by 8329.22% in 2022 and then surged by 8522.12% in 2023.
- Over the past 5 years, RedHill Biopharma's Other Gross PP&E Adjustments (Quarter) stood at -$3.7 million in 2021, then tumbled by 83.29% to -$6.7 million in 2022, then surged by 85.22% to -$989000.0 in 2023, then surged by 69.46% to -$302000.0 in 2024, then surged by 46.03% to -$163000.0 in 2025.
- Its Other Gross PP&E Adjustments was -$163000.0 in Q2 2025, compared to -$302000.0 in Q4 2024 and -$469000.0 in Q2 2024.